Skip to content

Drug interactions

Oxcarbazepine + Pacritinib

Severity: Moderate

Oxcarbazepine and Pacritinib: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Oxcarbazepine is a weak-to-moderate inducer of CYP3A4 and may lower pacritinib exposure. Reduced pacritinib levels could lead to loss of efficacy in myelofibrosis. Pacritinib labeling advises avoiding strong CYP3A4 inducers, and the effect of oxcarbazepine is expected to be smaller.

What this interaction means in plain words

Oxcarbazepine and Pacritinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Oxcarbazepine belongs to Central Nervous System; Pacritinib belongs to Oncology.

Evidence level: Low

Why it happens

Oxcarbazepine and its metabolite induce CYP3A4, increasing the metabolism of pacritinib.

What to do

Monitor spleen and symptom response to pacritinib, and consider an alternative anticonvulsant without CYP3A4 induction if response declines.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Oxcarbazepine and Pacritinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Oxcarbazepine with Pacritinib?

MediHelp rates the interaction as moderate. Oxcarbazepine and Pacritinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Oxcarbazepine is a weak-to-moderate inducer of CYP3A4 and may lower pacritinib exposure. Reduced pacritinib levels could lead to loss of efficacy in myelofibrosis. Pacritinib labeling advises avoiding strong CYP3A4 inducers, and the effect of oxcarbazepine is expected to be smaller.

How serious is the interaction between Oxcarbazepine and Pacritinib?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor spleen and symptom response to pacritinib, and consider an alternative anticonvulsant without CYP3A4 induction if response declines.

What other medicines interact with Oxcarbazepine?

MediHelp also lists interactions of Oxcarbazepine with, for example, Cabotegravir, Rilpivirine, Artemether / lumefantrine. The full list is on the Oxcarbazepine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in